Skip to main content

Table 3 Results of Overall Survival Analysis by Cox Proportional Hazards Model for the full dataset

From: Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer

Prognostic Factor

Univariate (n = 403)

Multivariate (n = 360c)

 

HR (95 % CI)

P-value

HR (95 % CI)

P-value

Menacalc

 

High vs. Low

1.84 (1.08, 3.14)

0.0248

2.18 (1.19, 4.00)

0.0199

Her2a

 

Positive vs. Negative

1.71 (0.77, 3.79)

0.1855

1.43 (0.58, 3.53)

0.4341

Tumor Size

 

≥2 cm vs. <2 cm

1.40 (0.83, 2.35)

0.2024

1.45 (0.80, 2.66)

0.2234

ERa

 

Negative vs. Positive

1.18 (0.65, 2.13)

0.5858

1.09 (0.57, 2.08)

0.7952

PRa

 

Positive vs. Negative

2.36 (1.32, 4.25)

0.0040

NAb

NAb

Histological grade

 

Grade 2-3 vs. Grade 1

1.62 (0.82, 3.22)

0.1682

1.27 (0.59, 2.72)

0.5450

 

ND vs. Grade 1

1.06 (0.33, 3.42)

0.9264

0.75 (0.22, 2.49)

0.6354

Lymphatic invasion

 

Present vs. Absent

1.78 (0.97, 3.26)

0.0614

1.67 (0.85, 3.30)

0.1359

Treatment

 

Yes vs. No

0.60 (0.35, 1.00)

0.0514

0.54 (0.29, 0.99)

0.0454

Age, years

 

≥50 vs. <50

1.90 (1.06, 3.43)

0.0319

1.93 (1.02, 3.65)

0.0425

  1. aIHC marker
  2. bPR was not included as ER and PR are correlated
  3. cTumors excluded if missing data for either Her2 or ER